NCT04609189View on ClinicalTrials.gov

Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

July 12, 2012

Primary Completion Date

May 2, 2014

Study Completion Date

May 2, 2014

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

Pearlium/EffectiCal

Oral administration of Pearlium/EffectiCal.

DRUG

Calcium carbonate/vitamin D3

Oral administration of Calcium Carbonate/Vitamin D3

All Listed Sponsors
lead

University of Alberta

OTHER

NCT04609189 - Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss | Biotech Hunter | Biotech Hunter